GlassScriptPhysician profile
Alejandra M Del Toro
NPI 1285881136
$22,758.79
in general payments reported to CMS, 2019-2025
89 companies · $6,403 in 2025
The $6,403 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $1,061 · 2021: $1,730 · 2022: $1,796 · 2023: $4,905 · 2024: $5,559 · 2025: $6,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Long Term Medical Supply Or Device Loan: $2,299 · Education: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,240.98 |
| Long Term Medical Supply Or Device Loan | $2,299.02 |
| Education | $327.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,476.02 | 2019-2025 | |
| Janssen Biotech, INC. | $1,528.67 | 2019-2025 | Erleada, Darzalex, Tecvayli |
| Pfizer INC. | $1,236.22 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,113.35 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $1,099.32 | 2019-2025 | Lynparza, Calquence, Tagrisso |
| Myriad Genetic Laboratories, INC. | $840.40 | 2023-2025 | Myrisk, Mychoice Cdx |
| Incyte Corporation | $773.24 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Coherus Oncology, INC. | $765.29 | 2020-2024 | |
| Glaxosmithkline, LLC. | $725.12 | 2023-2025 | Ojjaara, Zejula, Jemperli |
| Daiichi Sankyo INC. | $708.54 | 2020-2025 | Enhertu, Datroway, Injectafer |
| E.R. Squibb & Sons, L.L.C. | $675.16 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Celgene Corporation | $634.80 | 2020-2025 | Reblozyl, Pomalyst |
| Genzyme Corporation | $599.24 | 2019-2025 | |
| Beigene USA, INC. | $442.86 | 2020-2025 | Brukinsa, Tevimbra |
| Amgen INC. | $413.15 | 2019-2023 | Lumakras |
Show all 89 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $398.47 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $379.01 | 2019-2025 | Ninlaro, Alunbrig, Iclusig |
| Seagen INC. | $349.26 | 2019-2023 | Tukysa, Tivdak |
| Pharmacyclics LLC, An Abbvie Company | $314.87 | 2019-2021 | |
| Lilly USA, LLC | $295.02 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Abbvie INC. | $288.82 | 2021-2025 | Venclexta, Lupron Depot |
| Genentech USA, INC. | $282.25 | 2019-2025 | Tecentriq, Polivy, Alecensa |
| Astellas Pharma US INC | $254.79 | 2019-2025 | Xospata, Xtandi |
| Rigel Pharmaceuticals, INC. | $249.66 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Emd Serono, INC. | $229.12 | 2022-2024 | Bavencio |
| Karyopharm Therapeutics INC. | $225.99 | 2020-2025 | Xpovio |
| Regeneron Healthcare Solutions, INC. | $208.98 | 2021-2025 | Libtayo, Lynozyfic |
| Pharmacosmos Therapeutics INC. | $204.84 | 2022-2025 | Monoferric |
| Adaptive Biotechnologies Corporation | $202.92 | 2023-2025 | Clonoseq |
| Exelixis INC. | $194.10 | 2019-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $188.28 | 2020-2025 | Ultomiris |
| Puma Biotechnology, INC. | $187.30 | 2019-2025 | |
| Eisai INC. | $176.40 | 2019-2024 | |
| Sobi, INC | $175.67 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $169.21 | 2019-2025 | Onivyde, Somatuline Depot |
| Servier Pharmaceuticals LLC | $166.90 | 2023-2025 | |
| Array Biopharma INC | $159.51 | 2023-2025 | Lorbrena, Braftovi, Mektovi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.64 | 2019-2025 | Gilotrif, Ofev |
| Amneal Pharmaceuticals LLC | $126.06 | 2023-2025 | Neulasta, Neupogen, Avastin |
| Mirati Therapeutics, INC. | $119.90 | 2023-2024 | Krazati |
| Tempus Ai, INC | $112.79 | 2024-2025 | Xt Cdx |
| Pharmaessentia USA Corporation | $111.92 | 2023-2024 | Besremi |
| Gilead Sciences, INC. | $106.44 | 2024-2025 | Trodelvy |
| Stemline Therapeutics INC. | $105.45 | 2023-2025 | Orserdu |
| Tersera Therapeutics LLC | $86.37 | 2022-2023 | Xermelo, Zoladex |
| Taiho Oncology, INC. | $83.13 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $79.56 | 2023-2025 | |
| Kyowa Kirin, INC. | $75.71 | 2021-2025 | Poteligeo |
| Genmab U.S., INC. | $71.87 | 2024-2025 | Epkinly |
| Sumitomo Pharma America, INC. | $71.70 | 2023 | Myfembree |
| Clovis Oncology, INC. | $69.77 | 2019-2020 | |
| Deciphera Pharmaceuticals INC. | $68.61 | 2021-2024 | Qinlock |
| Pharmaand Gmbh | $49.02 | 2025 | Rubraca |
| Caris Mpi, INC. | $48.13 | 2025 | Mi Cancer Seek |
| Dendreon Pharmaceuticals LLC | $44.92 | 2025 | Provenge |
| Springworks Therapeutics, INC. | $44.31 | 2024-2025 | Gomekli, Ogsiveo |
| Adc Therapeutics America, INC. | $43.66 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $41.33 | 2024 | |
| Kite Pharma, INC. | $38.78 | 2023 | Yescarta |
| Legend Biotech USA INC. | $37.78 | 2024 | |
| Tolmar, INC. | $36.18 | 2025 | Rubraca, Eligard |
| Apellis Pharmaceuticals, INC. | $35.67 | 2024 | Empaveli |
| Ge Healthcare | $35.19 | 2021 | |
| Cti Biopharma Corp. | $33.82 | 2023 | Vonjo |
| Teva Pharmaceuticals USA, INC. | $30.81 | 2019 | |
| Agios Pharmaceuticals, INC. | $30.35 | 2022-2024 | |
| Fennec Pharmaceuticals, INC. | $29.23 | 2024 | Pedmark |
| Janssen Scientific Affairs, LLC | $28.22 | 2019 | |
| Blueprint Medicines Corporation | $28.02 | 2020-2021 | |
| Blue Earth Diagnostics | $27.44 | 2024 | |
| Morphosys, US INC. | $26.15 | 2021-2023 | Monjuvi |
| Beone Medicines USA, INC. | $23.62 | 2025 | Brukinsa |
| Iovance Biotherapeutics, INC. | $23.58 | 2025 | Amtagvi |
| Boston Scientific Corporation | $21.87 | 2024 | Spaceoar Vue System - 10ml |
| Alnylam Pharmaceuticals INC. | $20.99 | 2023 | Givlaari |
| Novocure INC. | $20.41 | 2025 | Optune Lua (Novottf-200t) |
| Tactile Systems Technology INC | $19.55 | 2021 | |
| Myovant Sciences INC. | $19.44 | 2021 | |
| Biocon Biologics INC | $19.42 | 2024 | Ogivri |
| Azurity Pharmaceuticals, INC. | $19.37 | 2024 | Vivimusta |
| Foundation Medicine, INC. | $18.77 | 2021 | |
| Sirtex Medical INC | $16.54 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.99 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $13.75 | 2019 | |
| Epizyme, INC. | $12.46 | 2020 | |
| Dova Pharmaceuticals | $12.45 | 2021 | |
| Immunomedics, INC. | $12.34 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.26 | 2019 | |
| Tesaro, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
Kisqali $2,406Keytruda $719Myrisk $664Ojjaara $619Enhertu $557Reblozyl $467Lynparza $467Udenyca $465Erleada $435Xtandi $427Jakafi $398Talzenna $309Opdivo $303Orgovyx $299Elrexfio $258Jaypirca $251Nubeqa $245Verzenio $227Xofigo $223Darzalex $222Brukinsa $216Clonoseq $203Rezlidhia $203Tavalisse $203Adcetris $194Ibrance $194Calquence $190Bosulif $186Sarclisa $184Mychoice Cdx $177Libtayo $175Pluvicto $168Tecvayli $168Rybrevant $160Braftovi $160Lorbrena $160Tukysa $159Ultomiris $158Monoferric $155Xpovio $155Piqray $153Retevmo $148Cabometyx $145Welireg $140Tagrisso $140Krazati $136Doptelet $136Ninlaro $128Imfinzi $127Lenvima $126Tibsovo $126Venclexta $124Cablivi $124Enjaymo $124Mektovi $113Xt Cdx $113Besremi $112Orserdu $105Stivarga $104Tecentriq $100Onivyde $95.85Xalkori $93.19Alunbrig $92.86Padcev $92.45Gavreto $88.50Rubraca $85.20Avastin $80.63Neupogen $80.63Neulasta $80.63Zepzelca $79.56Elahere $79.20Polivy $74.51Vonjo $73.46Epkinly $71.87Myfembree $71.70Tivdak $71.58Opdualag $71.55Bavencio $70.16Inlyta $68.82Iclusig $67.69Lonsurf $65.76Inqovi $65.76Carvykti $65.43Xospata $64.18Trodelvy $63.45Fruzaqla $61.18Datroway $58.52Zejula $55.00Jemperli $55.00Poteligeo $51.73Shingrix $51.26Qinlock $51.14Xermelo $49.94Mi Cancer Seek $48.13Idhifa $47.45Gilotrif $45.96Alecensa $45.56Alymsys $45.43Provenge $44.92Akeega $43.82
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandra Del Toro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.